Market Cap 174.25M
Revenue (ttm) 1.67M
Net Income (ttm) -11.24M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -673.05%
Debt to Equity Ratio 0.00
Volume 1,400
Avg Vol 15,766
Day's Range N/A - N/A
Shares Out 285.52M
Stochastic %K 25%
Beta 0.23
Analysts Strong Buy
Price Target N/A

Company Profile

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal a...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 416 626 3233
Fax: 866 332 2699
Address:
135 The West Mall, Unit 2, Toronto, Canada
Latest News on EDTXF
No data available.